MITOCHONDRIAL RESEARCH
TARGETED TETRAPEPTIDE
SS-31 is a synthetic four-amino-acid peptide designed to concentrate at the inner mitochondrial membrane.
PEPTIDE PERFORMANCE RESEARCH LIBRARY
SS-31 RESEARCH.
An educational overview of SS-31, a mitochondria-targeted tetrapeptide investigated for its interactions with mitochondrial membranes, cardiolipin, cellular energetics, and oxidative stress.
RESEARCH OVERVIEW
WHAT IS SS-31?
MEMBRANE BIOLOGY
CARDIOLIPIN
A major area of investigation involves interactions between SS-31 and cardiolipin, a phospholipid important to mitochondrial membrane structure and function.
CLINICAL DEVELOPMENT
HUMAN RESEARCH
SS-31, also studied clinically as elamipretide, has progressed beyond laboratory research into human clinical studies involving several mitochondrial-related conditions.
MECHANISMS UNDER INVESTIGATION
MITOCHONDRIAL FUNCTION.
Research has focused on how SS-31 may influence mitochondrial membrane function and cellular energy production.
CARDIOLIPIN INTERACTION
Experimental evidence suggests SS-31 interacts with cardiolipin within the inner mitochondrial membrane, an area important to respiratory-chain organization.
CELLULAR ENERGY
Researchers have investigated whether changes in mitochondrial membrane function can influence oxidative phosphorylation and cellular energy production.
OXIDATIVE STRESS
Preclinical studies have examined SS-31 in models involving mitochondrial reactive oxygen species and oxidative stress.
RESEARCH AREAS
WHAT HAS BEEN STUDIED?
MITOCHONDRIAL BIOLOGY
BIOENERGETICS
Laboratory studies have investigated mitochondrial respiration, membrane integrity, ATP production, and cellular responses to mitochondrial stress.
TISSUE RESEARCH
MULTIPLE SYSTEMS
Preclinical research has included skeletal muscle, cardiac tissue, kidney, nervous-system, and other models affected by mitochondrial dysfunction or oxidative stress.
HUMAN STUDIES
CLINICAL INVESTIGATION
Elamipretide has been evaluated in clinical research involving mitochondrial disease and other conditions in which impaired mitochondrial function may contribute to disease biology.
IMPORTANT CONTEXT
RESEARCH DOES NOT EQUAL PROVEN BENEFIT.
Mechanistic findings and promising results from experimental models do not by themselves demonstrate clinical effectiveness.
Results can differ substantially between cellular studies, animal models, individual clinical trials, diseases, endpoints, and study populations.
RESEARCH LIMITATIONS
WHAT WE DON'T KNOW YET.
Although SS-31 has a larger body of research than many experimental peptides, clinical results must be interpreted according to the specific disease, trial design, endpoints, and population studied.
Findings from one experimental model or clinical condition cannot automatically be generalized to unrelated uses, healthy populations, athletic performance, or other outcomes.
RESEARCH SOURCES
PUBLISHED REFERENCES.
Mitochondrial Targeting Research
Foundational SS-31 research has examined selective
mitochondrial localization and interactions with the
inner mitochondrial membrane.
Cardiolipin Research
Experimental studies have investigated interactions between
SS-31 and cardiolipin and their potential influence on
mitochondrial membrane and respiratory function.
Oxidative Stress Research
Cellular and animal models have evaluated SS-31 in conditions
involving mitochondrial oxidative stress and impaired
bioenergetics.
Clinical Research
Elamipretide has undergone human clinical investigation
across several mitochondrial and mitochondrial-associated
disease settings.
EDUCATIONAL RESEARCH NOTICE
Information presented in the Peptide Performance Research Library is provided for general educational and scientific reference purposes only.
This content is not medical advice, diagnosis, treatment guidance, dosing information, or personal-use instruction. Research findings may change as additional evidence becomes available.